Optimization of betulinic acid analogs for T-type calcium channel inhibition for non-addictive relief of chronic pain
Ended Project Grant Awarded Last action
- Award ID
- R41DA050364
- Recipient
-
Regulonix LLC UEI RZ32MNG7DH93
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,696
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Place of performance
- Arizona, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,696 |
Quick answers
Who received award R41DA050364?
R41DA050364 was awarded to Regulonix LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2019.
How much is award R41DA050364 worth?
$224,696 has been obligated on R41DA050364.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award